Halozyme Therapeutics IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 83.3 USD | 84,44 USD | 58,53 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 86,889 USD | 2 | 2 | 3 | 1 | 0 |
| #Shares | Short [%] | Short Ratio |
| 118.613.000 | 14,5 | 6,68 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Halozyme Therapeutics Inc
Mitarbeiter 423
Handelsplatz NASDAQ
Ticker Symbol HALO
IPO Datum 2004-03-16
Adresse 12390 El Camino Real, San Diego, CA, United States, 92130
Webseite https://halozyme.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Helen I. Torley M.B. Ch. B., M.R.C.P. | President, CEO & Director |
| 2 | Mr. Mark Snyder Esq. | Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary |
| 3 | Mr. Darren Snellgrove | Senior VP & CFO |
| 4 | Ms. Tram Bui | Head of Investor Relations & Corporate Communications |
| 5 | Mr. David A. Ramsay MBA | President of Drug Delivery |
| 6 | Dr. Christopher Wahl M.B.A., M.D. | Chief Scientific Officer |
| 7 | Dr. Charles P. Theuer M.D., Ph.D. | Chief Medical Officer |
| 8 | Mr. Paul Spence | Chief Commercial Officer |
| 9 | Mr. Rhys de Callier | Chief Strategy Officer |
| 10 | Mr. Chase Coffman Ph.D. | President of Hypercon |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 5 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 6 | Amvescap Plc. | 0,00% | 0,00 Mio. USD |
| 7 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 8 | Boston Partners Global Investors, Inc | 0,00% | 0,00 Mio. USD |
| 9 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 10 | William Blair Investment Management, LLC | 0,00% | 0,00 Mio. USD |
| 11 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 12 | Snyder Capital Management LP | 0,00% | 0,00 Mio. USD |
| 13 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 14 | Arrowstreet Capital Limited Partnership | 0,00% | 0,00 Mio. USD |
| 15 | NORGES BANK | 0,00% | 0,00 Mio. USD |
| 16 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |
| 17 | AllianceBernstein L.P. | 0,00% | 0,00 Mio. USD |
| 18 | Royal London Asset Management Ltd | 0,00% | 0,00 Mio. USD |
| 19 | Jupiter Asset Management Limited | 0,00% | 0,00 Mio. USD |
| 20 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |